Hannes A. Loebner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hannes A. Loebner has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Michael K. Fix
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland, Freiburgstrasse 18, Bern, 3010, Switzerland
10 shared publications - Silvan Mueller
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Freiburgstrasse 18, Bern, 3010, Switzerland
9 shared publications Werner Volken
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland, Freiburgstrasse 18, Bern, 3010, Switzerland
8 shared publications- Jenny Bertholet
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland
7 shared publications - Marco Stampanoni
PSI Center for Photon Science, Paul Scherrer Institute, 5232 Villigen PSI, Switzerland
6 shared publications - Peter Manser
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland, Freiburgstrasse 18, Bern, 3010, Switzerland
6 shared publications
Latest Publications
- Open Access
- 15 April 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (9)
Robust optimized dynamic mixed-beam arc radiotherapy for left-sided breast radiotherapy under deep inspiration breath-hold variations
Background and Purpose: Dynamic mixed-beam arc radiotherapy (DYMBARC) combines intensity-modulated electron- and photon-arcs in order to reduce normal tissue dose compared to photon-only techniques while ensuring similar target coverage. For left-sided breast, deep inspiration breath-hold (DIBH) improves heart sparing and mitigates breathing motion. However, dose delivery uncertainties remain due to inter- and intra-breath-hold variations. We assess robustness and dosimetric plan quality of robust optimized (RO)-DYMBARC under DIBH variations with comparison to VMAT. Materials and Methods: Ten cases were created using the XCAT anthropomorphic phantom. NiftyReg was used to obtain deformation vector fields (DVFs) for DIBH variations. For each case, three plans were created: PTV-based VMAT, RO-VMAT, and RO-DYMBARC, prescribed 42.4 Gy to the target volume (PTV or CTV for RO plans). Robustness to DIBH variations was assessed by recalculating doses using the DVFs and deformable voxel geometry Monte Carlo simulations. Dosimetric endpoints for targets and organs at risk (OARs) were compared using Wilcoxon matched-pair signed-rank test (α=0.05). Results: RO-DYMBARC demonstrated significantly better OAR sparing compared to VMAT, with mean dose to heart and contralateral breast up to 1 Gy lower than PTV-based VMAT. Target coverage and robustness to DIBH variations were similar across all plans. For OARs, DIBH variations led to dose differences ≤ 0.1 Gy for all plans and endpoints compared to the nominal scenario. Conclusion: RO-DYMBARC provided superior dosimetric plan quality with similar robustness to DIBH variations compared to VMAT. The dosimetric advantage of RO-DYMBARC was maintained in the presence of DIBH variations.
- 15 April 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (9)
Open AccessRobust optimized dynamic mixed-beam arc radiotherapy for left-sided breast radiotherapy under deep inspiration breath-hold variations
Background and Purpose: Dynamic mixed-beam arc radiotherapy (DYMBARC) combines intensity-modulated electron- and photon-arcs in order to reduce normal tissue dose compared to photon-only techniques while ensuring similar target coverage. For left-sided breast, deep inspiration breath-hold (DIBH) improves heart sparing and mitigates breathing motion. However, dose delivery uncertainties remain due to inter- and intra-breath-hold variations. We assess robustness and dosimetric plan quality of robust optimized (RO)-DYMBARC under DIBH variations with comparison to VMAT. Materials and Methods: Ten cases were created using the XCAT anthropomorphic phantom. NiftyReg was used to obtain deformation vector fields (DVFs) for DIBH variations. For each case, three plans were created: PTV-based VMAT, RO-VMAT, and RO-DYMBARC, prescribed 42.4 Gy to the target volume (PTV or CTV for RO plans). Robustness to DIBH variations was assessed by recalculating doses using the DVFs and deformable voxel geometry Monte Carlo simulations. Dosimetric endpoints for targets and organs at risk (OARs) were compared using Wilcoxon matched-pair signed-rank test (α=0.05). Results: RO-DYMBARC demonstrated significantly better OAR sparing compared to VMAT, with mean dose to heart and contralateral breast up to 1 Gy lower than PTV-based VMAT. Target coverage and robustness to DIBH variations were similar across all plans. For OARs, DIBH variations led to dose differences ≤ 0.1 Gy for all plans and endpoints compared to the nominal scenario. Conclusion: RO-DYMBARC provided superior dosimetric plan quality with similar robustness to DIBH variations compared to VMAT. The dosimetric advantage of RO-DYMBARC was maintained in the presence of DIBH variations.
- Open Access
- 21 April 2025
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 36 (1) , 47-59
Robustness assessment of radiotherapy treatment plans in Switzerland
- 21 April 2025
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 36 (1) , 47-59
Open AccessRobustness assessment of radiotherapy treatment plans in Switzerland
- Open Access
- 17 March 2025
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 36 (1) , 36-46
DeepSMCP – Deep-learning powered denoising of Monte Carlo dose distributions within the Swiss Monte Carlo Plan
- 17 March 2025
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 36 (1) , 36-46
Open AccessDeepSMCP – Deep-learning powered denoising of Monte Carlo dose distributions within the Swiss Monte Carlo Plan
- Open Access
- 26 October 2024
- Published by Wiley in Medical Physics
- Vol. 52 (1) , 489-503
Dosimetric optimization for dynamic mixed beam arc therapy (DYMBARC)
Background: Non‐coplanarity and mixed beam modality could be combined to further enhance dosimetric treatment plan quality. We introduce dynamic mixed beam arc therapy (DYMBARC) as an innovative technique that combines non‐coplanar photon and electron arcs, dynamic gantry and collimator rotations, and intensity modulation with photon multileaf collimator (MLC). However, finding favorable beam directions for DYMBARC is challenging due to the large solution space, machine component constraints, and optimization parameters, posing a highly non‐convex optimization problem.Purpose: To establish DYMBARC and solve the pathfinding challenge by employing direct aperture optimization (DAO) to determine the table angles and gantry angle ranges of photon and electron arcs for different clinically motivated cases.Methods: The method starts by generating a grid of beam directions based on user‐defined resolutions along the gantry and table angle axes for each beam quality considered. Beam directions causing collisions or entering through the end of CT are excluded. For electrons, a fixed source‐to‐surface distance of 80 cm is used to reduce in‐air scatter. Electron beam energies with insufficient range to reach the target or beam directions impinging on the table before reaching the patient are excluded. The remaining beam directions form the pathfinding solution space. Promising photon and electron MLC‐defined apertures, with associated monitor unit (MU) weights, are iteratively added using a hybrid‐DAO algorithm. This algorithm combines column generation to add apertures and simulated annealing to further refine aperture shapes and weights. Apertures are added until the requested number of paths are formed and the user‐defined maximum total gantry angle range is reached. Paths are resampled to a finer gantry angle resolution and subject to DAO for simultaneous optimization of beam intensities along the photon/electron arcs. Subsequent final dose calculation and MU weight reoptimization result in a deliverable DYMBARC plan. DYMBARC plans are created for three clinically motivated cases (brain, breast, and pelvis) and compared to DYMBARC variants: colli‐DTRT (dynamic collimator trajectory radiotherapy) using non‐coplanar photon arcs; and Arc‐MBRT (mixed beam radiotherapy) using photons and electrons but restricted to coplanar setup. Additionally, a manually defined volumetric modulated arc therapy (VMAT) setup serves as a reference clinical technique. Dose distributions, dose‐volume histograms, and dosimetric endpoints are evaluated. Dosimetric validation with radiochromic film measurements (gamma evaluation, 3% / 2 mm (global), 10% dose threshold) is performed on a TrueBeam system in developer mode for one case.Results: While maintaining similar target coverage and homogeneity, DYMBARC reduced mean doses to organs‐at‐risk compared to VMAT by an average of 3.2, 0.5, and 2.9 Gy for the brain, breast, and pelvis cases, respectively. Similar or smaller mean dose reductions were observed for Arc‐MBRT or colli‐DTRT, compared to VMAT. Electron contributions to the mean planning target volume dose ranged from 2% to 34% for DYMBARC and from 11% to 40% for Arc‐MBRT. Measurement validation showed >99.7% gamma passing rate.Conclusions: DYMBARC was successfully established using a dosimetrically optimized pathfinding approach, combining non‐coplanarity with mixed beam modality. DYMBARC facilitated the determination of photon and electron contributions on a case‐by‐case basis, enhancing more personalized treatment modalities.
- 26 October 2024
- Published by Wiley in Medical Physics
- Vol. 52 (1) , 489-503
Open AccessDosimetric optimization for dynamic mixed beam arc therapy (DYMBARC)
Background: Non‐coplanarity and mixed beam modality could be combined to further enhance dosimetric treatment plan quality. We introduce dynamic mixed beam arc therapy (DYMBARC) as an innovative technique that combines non‐coplanar photon and electron arcs, dynamic gantry and collimator rotations, and intensity modulation with photon multileaf collimator (MLC). However, finding favorable beam directions for DYMBARC is challenging due to the large solution space, machine component constraints, and optimization parameters, posing a highly non‐convex optimization problem.Purpose: To establish DYMBARC and solve the pathfinding challenge by employing direct aperture optimization (DAO) to determine the table angles and gantry angle ranges of photon and electron arcs for different clinically motivated cases.Methods: The method starts by generating a grid of beam directions based on user‐defined resolutions along the gantry and table angle axes for each beam quality considered. Beam directions causing collisions or entering through the end of CT are excluded. For electrons, a fixed source‐to‐surface distance of 80 cm is used to reduce in‐air scatter. Electron beam energies with insufficient range to reach the target or beam directions impinging on the table before reaching the patient are excluded. The remaining beam directions form the pathfinding solution space. Promising photon and electron MLC‐defined apertures, with associated monitor unit (MU) weights, are iteratively added using a hybrid‐DAO algorithm. This algorithm combines column generation to add apertures and simulated annealing to further refine aperture shapes and weights. Apertures are added until the requested number of paths are formed and the user‐defined maximum total gantry angle range is reached. Paths are resampled to a finer gantry angle resolution and subject to DAO for simultaneous optimization of beam intensities along the photon/electron arcs. Subsequent final dose calculation and MU weight reoptimization result in a deliverable DYMBARC plan. DYMBARC plans are created for three clinically motivated cases (brain, breast, and pelvis) and compared to DYMBARC variants: colli‐DTRT (dynamic collimator trajectory radiotherapy) using non‐coplanar photon arcs; and Arc‐MBRT (mixed beam radiotherapy) using photons and electrons but restricted to coplanar setup. Additionally, a manually defined volumetric modulated arc therapy (VMAT) setup serves as a reference clinical technique. Dose distributions, dose‐volume histograms, and dosimetric endpoints are evaluated. Dosimetric validation with radiochromic film measurements (gamma evaluation, 3% / 2 mm (global), 10% dose threshold) is performed on a TrueBeam system in developer mode for one case.Results: While maintaining similar target coverage and homogeneity, DYMBARC reduced mean doses to organs‐at‐risk compared to VMAT by an average of 3.2, 0.5, and 2.9 Gy for the brain, breast, and pelvis cases, respectively. Similar or smaller mean dose reductions were observed for Arc‐MBRT or colli‐DTRT, compared to VMAT. Electron contributions to the mean planning target volume dose ranged from 2% to 34% for DYMBARC and from 11% to 40% for Arc‐MBRT. Measurement validation showed >99.7% gamma passing rate.Conclusions: DYMBARC was successfully established using a dosimetrically optimized pathfinding approach, combining non‐coplanarity with mixed beam modality. DYMBARC facilitated the determination of photon and electron contributions on a case‐by‐case basis, enhancing more personalized treatment modalities.
- Open Access
- 22 October 2024
- Published by Wiley in Medical Physics
- Vol. 52 (2) , 1281-1292
Monte Carlo dose calculation for photon and electron radiotherapy on dynamically deforming anatomy
Background: Dose calculation in radiotherapy aims to accurately estimate and assess the dose distribution of a treatment plan. Monte Carlo (MC) dose calculation is considered the gold standard owing to its ability to accurately simulate particle transport in inhomogeneous media. However, uncertainties such as the patient's dynamically deforming anatomy can still lead to differences between the delivered and planned dose distribution.Purpose: Development and validation of a deformable voxel geometry for MC dose calculations (DefVoxMC) to account for dynamic deformation in the dose calculation process of photon‐ and electron‐based radiotherapy treatment plans for clinically motivated cases.Methods: DefVoxMC relies on the subdivision of a regular voxel geometry into dodecahedrons. It allows shifting the dodecahedrons’ corner points according to the deformation in the patient's anatomy using deformation vector fields (DVF). DefVoxMC is integrated into the Swiss Monte Carlo Plan (SMCP) to allow the MC dose calculation of photon‐ and electron‐based treatment plans on the deformable voxel geometry. DefVoxMC is validated in two steps. A compression test and a Fano test are performed in silico. Delta4 (for photon beams) and EBT4 film measurements in a cubic PMMA phantom (for electron beams) are performed on a TrueBeam in Developer Mode for clinically motivated treatment plans. During these measurements, table motion is used to mimic rigid dynamic patient motion. The measured and calculated dose distributions are compared using gamma passing rate (GPR) (3% / 2 mm (global), 10% threshold). DefVoxMC is used to study the impact of patient‐recorded breathing motion on the dose distribution for clinically motivated lung and breast cases, each prescribed 50 Gy to 50% of the target volume. A volumetric modulated arc therapy (VMAT) and an arc mixed‐beam radiotherapy (Arc‐MBRT) plan are created for the lung and breast case, respectively. For the dose calculation, the dynamic deformation of the patient's anatomy is described by DVFs obtained from deformable image registration of the different phases of 4DCTs. The resulting dose distributions are compared to the ones of the static situation using dose–volume histograms and dose differences.Results: DefVoxMC is successfully integrated into the SMCP to enable the MC dose calculation of photon‐ and electron‐based treatments on a dynamically deforming patient anatomy. The compression and the Fano test agree within 1.0% and 0.1% with the expected result, respectively. Delta4 and EBT4 film measurements agree with the calculated dose by a GPR >95%. For the clinically motivated cases, breathing motion resulted in areas with a dose increase of up to 26.9 Gy (lung) and up to 7.6 Gy (breast) compared to the static situation. The largest dose differences are observed in high‐dose‐gradient regions perpendicular to the beam plane, consequently decreasing the planning target volume coverage (V95%) by 4.2% for the lung case and 2.0% for the breast case.Conclusions: A novel method for MC dose calculation for photon‐ and electron‐based treatments on dynamically deforming anatomy is successfully developed and validated. Applying DefVoxMC to clinically motivated cases, we found that breathing motion has non‐negligible impact on the dosimetric plan quality.
- 22 October 2024
- Published by Wiley in Medical Physics
- Vol. 52 (2) , 1281-1292
Open AccessMonte Carlo dose calculation for photon and electron radiotherapy on dynamically deforming anatomy
Background: Dose calculation in radiotherapy aims to accurately estimate and assess the dose distribution of a treatment plan. Monte Carlo (MC) dose calculation is considered the gold standard owing to its ability to accurately simulate particle transport in inhomogeneous media. However, uncertainties such as the patient's dynamically deforming anatomy can still lead to differences between the delivered and planned dose distribution.Purpose: Development and validation of a deformable voxel geometry for MC dose calculations (DefVoxMC) to account for dynamic deformation in the dose calculation process of photon‐ and electron‐based radiotherapy treatment plans for clinically motivated cases.Methods: DefVoxMC relies on the subdivision of a regular voxel geometry into dodecahedrons. It allows shifting the dodecahedrons’ corner points according to the deformation in the patient's anatomy using deformation vector fields (DVF). DefVoxMC is integrated into the Swiss Monte Carlo Plan (SMCP) to allow the MC dose calculation of photon‐ and electron‐based treatment plans on the deformable voxel geometry. DefVoxMC is validated in two steps. A compression test and a Fano test are performed in silico. Delta4 (for photon beams) and EBT4 film measurements in a cubic PMMA phantom (for electron beams) are performed on a TrueBeam in Developer Mode for clinically motivated treatment plans. During these measurements, table motion is used to mimic rigid dynamic patient motion. The measured and calculated dose distributions are compared using gamma passing rate (GPR) (3% / 2 mm (global), 10% threshold). DefVoxMC is used to study the impact of patient‐recorded breathing motion on the dose distribution for clinically motivated lung and breast cases, each prescribed 50 Gy to 50% of the target volume. A volumetric modulated arc therapy (VMAT) and an arc mixed‐beam radiotherapy (Arc‐MBRT) plan are created for the lung and breast case, respectively. For the dose calculation, the dynamic deformation of the patient's anatomy is described by DVFs obtained from deformable image registration of the different phases of 4DCTs. The resulting dose distributions are compared to the ones of the static situation using dose–volume histograms and dose differences.Results: DefVoxMC is successfully integrated into the SMCP to enable the MC dose calculation of photon‐ and electron‐based treatments on a dynamically deforming patient anatomy. The compression and the Fano test agree within 1.0% and 0.1% with the expected result, respectively. Delta4 and EBT4 film measurements agree with the calculated dose by a GPR >95%. For the clinically motivated cases, breathing motion resulted in areas with a dose increase of up to 26.9 Gy (lung) and up to 7.6 Gy (breast) compared to the static situation. The largest dose differences are observed in high‐dose‐gradient regions perpendicular to the beam plane, consequently decreasing the planning target volume coverage (V95%) by 4.2% for the lung case and 2.0% for the breast case.Conclusions: A novel method for MC dose calculation for photon‐ and electron‐based treatments on dynamically deforming anatomy is successfully developed and validated. Applying DefVoxMC to clinically motivated cases, we found that breathing motion has non‐negligible impact on the dosimetric plan quality.
- Open Access
- 12 August 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (16) , 165032
Robust optimization and assessment of dynamic trajectory and mixed-beam arc radiotherapy: a preliminary study
Objective. Dynamic trajectory radiotherapy (DTRT) and dynamic mixed-beam arc therapy (DYMBARC) exploit non-coplanarity and, for DYMBARC, simultaneously optimized photon and electron beams. Margin concepts to account for set-up uncertainties during delivery are ill-defined for electron fields. We develop robust optimization for DTRT&DYMBARC and compare dosimetric plan quality and robustness for both techniques and both optimization strategies for four cases. Approach. Cases for different treatment sites and clinical target volume (CTV) to planning target volume (PTV) margins, m , were investigated. Dynamic gantry-table-collimator photon paths were optimized to minimize PTV/organ-at-risk (OAR) overlap in beam’s-eye-view and minimize potential photon multileaf collimator (MLC) travel. For DYMBARC plans, non-isocentric partial electron arcs or static fields with shortened source-to-surface distance (80 cm) were added. Direct aperture optimization (DAO) was used to simultaneously optimize MLC-based intensity modulation for both photon and electron beams yielding deliverable PTV-based DTRT&DYMBARC plans. Robust-optimized plans used the same paths/arcs/fields. DAO with stochastic programming was used for set-up uncertainties with equal weights in all translational directions and magnitude δ such that m = 0.7 δ . Robust analysis considered random errors in all directions with or without an additional systematic error in the worst 3D direction for the adjacent OARs. Main results. Electron contribution was 7%–41% of target dose depending on the case and optimization strategy for DYMBARC. All techniques achieved similar CTV coverage in the nominal (no error) scenario. OAR sparing was overall better in the DYMBARC plans than in the DTRT plans and DYMBARC plans were generally more robust to the considered uncertainties. OAR sparing was better in the PTV-based than in robust-optimized plans for OARs abutting or overlapping with the target volume, but more affected by uncertainties. Significance. Better plan robustness can be achieved with robust optimization than with margins. Combining electron arcs/fields with non-coplanar photon trajectories further improves robustness and OAR sparing.
- 12 August 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (16) , 165032
Open AccessRobust optimization and assessment of dynamic trajectory and mixed-beam arc radiotherapy: a preliminary study
Objective. Dynamic trajectory radiotherapy (DTRT) and dynamic mixed-beam arc therapy (DYMBARC) exploit non-coplanarity and, for DYMBARC, simultaneously optimized photon and electron beams. Margin concepts to account for set-up uncertainties during delivery are ill-defined for electron fields. We develop robust optimization for DTRT&DYMBARC and compare dosimetric plan quality and robustness for both techniques and both optimization strategies for four cases. Approach. Cases for different treatment sites and clinical target volume (CTV) to planning target volume (PTV) margins, m , were investigated. Dynamic gantry-table-collimator photon paths were optimized to minimize PTV/organ-at-risk (OAR) overlap in beam’s-eye-view and minimize potential photon multileaf collimator (MLC) travel. For DYMBARC plans, non-isocentric partial electron arcs or static fields with shortened source-to-surface distance (80 cm) were added. Direct aperture optimization (DAO) was used to simultaneously optimize MLC-based intensity modulation for both photon and electron beams yielding deliverable PTV-based DTRT&DYMBARC plans. Robust-optimized plans used the same paths/arcs/fields. DAO with stochastic programming was used for set-up uncertainties with equal weights in all translational directions and magnitude δ such that m = 0.7 δ . Robust analysis considered random errors in all directions with or without an additional systematic error in the worst 3D direction for the adjacent OARs. Main results. Electron contribution was 7%–41% of target dose depending on the case and optimization strategy for DYMBARC. All techniques achieved similar CTV coverage in the nominal (no error) scenario. OAR sparing was overall better in the DYMBARC plans than in the DTRT plans and DYMBARC plans were generally more robust to the considered uncertainties. OAR sparing was better in the PTV-based than in robust-optimized plans for OARs abutting or overlapping with the target volume, but more affected by uncertainties. Significance. Better plan robustness can be achieved with robust optimization than with margins. Combining electron arcs/fields with non-coplanar photon trajectories further improves robustness and OAR sparing.
- Open Access
- 10 May 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 30, 100586
Robustness analysis of dynamic trajectory radiotherapy and volumetric modulated arc therapy plans for head and neck cancer
- 10 May 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 30, 100586
Open AccessRobustness analysis of dynamic trajectory radiotherapy and volumetric modulated arc therapy plans for head and neck cancer
- Open Access
- 25 September 2023
- Published by Wiley in Medical Physics
- Vol. 50 (11) , 7104-7117
Impact of the gradient in gantry‐table rotation on dynamic trajectory radiotherapy plan quality
Background: To improve organ at risk (OAR) sparing, dynamic trajectory radiotherapy (DTRT) extends VMAT by dynamic table and collimator rotation during beam‐on. However, comprehensive investigations regarding the impact of the gantry‐table (GT) rotation gradient on the DTRT plan quality have not been conducted.Purpose: To investigate the impact of a user‐defined GT rotation gradient on plan quality of DTRT plans in terms of dosimetric plan quality, dosimetric robustness, deliverability, and delivery time.Methods: The dynamic trajectories of DTRT are described by GT and gantry‐collimator paths. The GT path is determined by minimizing the overlap of OARs with planning target volume (PTV). This approach is extended to consider a GT rotation gradient by means of a maximum gradient of the path () between two adjacent control points () and maximum absolute change of G (). Four DTRT plans are created with different maximum G&∆G: & = 0.5&0.125 (DTRT‐1), 1&0.125 (DTRT‐2), 3&0.125 (DTRT‐3) and 3&1(DTRT‐4), including 3–4 dynamic trajectories, for three clinically motivated cases in the head and neck and brain region (A, B, and C). A reference VMAT plan for each case is created. For all plans, plan quality is assessed and compared. Dosimetric plan quality is evaluated by target coverage, conformity, and OAR sparing. Dosimetric robustness is evaluated against systematic and random patient‐setup uncertainties between in the lateral, longitudinal, and vertical directions, and machine uncertainties between in the dynamically rotating machine components (gantry, table, collimator rotation). Delivery time is recorded. Deliverability and delivery accuracy on a TrueBeam are assessed by logfile analysis for all plans and additionally verified by film measurements for one case. All dose calculations are Monte Carlo based.Results: The extension of the DTRT planning process with user‐defined to investigate the impact of the GT rotation gradient on plan quality is successfully demonstrated. With increasing , slight (case C, : up to−1Gy) and substantial (case A, : up to −9.3 Gy, caseB,: up to −4.7Gy) improvements in OAR sparing are observed compared to VMAT, while maintaining similar target coverage. All plans are delivered on the TrueBeam. Expected and actual machine position values recorded in the logfiles deviated by 96% (2%global/2 mm Gamma passing rate) with the dose calculation. With increasing , delivery time is prolonged by <2 min/trajectory (DTRT‐4) compared to VMAT and DTRT‐1. The DTRT plans for case A and B and the VMAT plan for case C plan reveal the best dosimetric robustness for the considered uncertainties.Conclusion: The impact of the GT rotation gradient on DTRT plan quality is comprehensively investigated for three cases in the head and neck and brain region. Increasing freedom in this gradient improves dosimetric plan quality at the cost of increased delivery time for the investigated cases. No clear dependency of GT rotation gradient on dosimetric robustness is observed.
- 25 September 2023
- Published by Wiley in Medical Physics
- Vol. 50 (11) , 7104-7117
Open AccessImpact of the gradient in gantry‐table rotation on dynamic trajectory radiotherapy plan quality
Background: To improve organ at risk (OAR) sparing, dynamic trajectory radiotherapy (DTRT) extends VMAT by dynamic table and collimator rotation during beam‐on. However, comprehensive investigations regarding the impact of the gantry‐table (GT) rotation gradient on the DTRT plan quality have not been conducted.Purpose: To investigate the impact of a user‐defined GT rotation gradient on plan quality of DTRT plans in terms of dosimetric plan quality, dosimetric robustness, deliverability, and delivery time.Methods: The dynamic trajectories of DTRT are described by GT and gantry‐collimator paths. The GT path is determined by minimizing the overlap of OARs with planning target volume (PTV). This approach is extended to consider a GT rotation gradient by means of a maximum gradient of the path () between two adjacent control points () and maximum absolute change of G (). Four DTRT plans are created with different maximum G&∆G: & = 0.5&0.125 (DTRT‐1), 1&0.125 (DTRT‐2), 3&0.125 (DTRT‐3) and 3&1(DTRT‐4), including 3–4 dynamic trajectories, for three clinically motivated cases in the head and neck and brain region (A, B, and C). A reference VMAT plan for each case is created. For all plans, plan quality is assessed and compared. Dosimetric plan quality is evaluated by target coverage, conformity, and OAR sparing. Dosimetric robustness is evaluated against systematic and random patient‐setup uncertainties between in the lateral, longitudinal, and vertical directions, and machine uncertainties between in the dynamically rotating machine components (gantry, table, collimator rotation). Delivery time is recorded. Deliverability and delivery accuracy on a TrueBeam are assessed by logfile analysis for all plans and additionally verified by film measurements for one case. All dose calculations are Monte Carlo based.Results: The extension of the DTRT planning process with user‐defined to investigate the impact of the GT rotation gradient on plan quality is successfully demonstrated. With increasing , slight (case C, : up to−1Gy) and substantial (case A, : up to −9.3 Gy, caseB,: up to −4.7Gy) improvements in OAR sparing are observed compared to VMAT, while maintaining similar target coverage. All plans are delivered on the TrueBeam. Expected and actual machine position values recorded in the logfiles deviated by 96% (2%global/2 mm Gamma passing rate) with the dose calculation. With increasing , delivery time is prolonged by <2 min/trajectory (DTRT‐4) compared to VMAT and DTRT‐1. The DTRT plans for case A and B and the VMAT plan for case C plan reveal the best dosimetric robustness for the considered uncertainties.Conclusion: The impact of the GT rotation gradient on DTRT plan quality is comprehensively investigated for three cases in the head and neck and brain region. Increasing freedom in this gradient improves dosimetric plan quality at the cost of increased delivery time for the investigated cases. No clear dependency of GT rotation gradient on dosimetric robustness is observed.
- Open Access
- 20 June 2023
- Published by Wiley in Medical Physics
- Vol. 50 (10) , 6535-6542
Technical note: Feasibility of gating for dynamic trajectory radiotherapy – Mechanical accuracy and dosimetric performance
Background: Dynamic trajectory radiotherapy (DTRT) extends state‐of‐the‐art volumetric modulated arc therapy (VMAT) by dynamic table and collimator rotations during beam‐on. The effects of intrafraction motion during DTRT delivery are unknown, especially regarding the possible interplay between patient and machine motion with additional dynamic axes.Purpose: To experimentally assess the technical feasibility and quantify the mechanical and dosimetric accuracy of respiratory gating during DTRT delivery.Methods: A DTRT and VMAT plan are created for a clinically motivated lung cancer case and delivered to a dosimetric motion phantom (MP) placed on the table of a TrueBeam system using Developer Mode. The MP reproduces four different 3D motion traces. Gating is triggered using an external marker block, placed on the MP. Mechanical accuracy and delivery time of the VMAT and DTRT deliveries with and without gating are extracted from the logfiles. Dosimetric performance is assessed by means of gamma evaluation (3% global/2 mm, 10% threshold).Results: The DTRT and VMAT plans are successfully delivered with and without gating for all motion traces. Mechanical accuracy is similar for all experiments with deviations <0.14° (gantry angle), <0.15° (table angle), <0.09° (collimator angle) and <0.08 mm (MLC leaf positions). For DTRT (VMAT), delivery times are 1.6–2.3 (1.6– 2.5) times longer with than without gating for all motion traces except one, where DTRT (VMAT) delivery is 5.0 (3.6) times longer due to a substantial uncorrected baseline drift affecting only DTRT delivery. Gamma passing rates with (without) gating for DTRT/VMAT were ≥96.7%/98.5% (≤88.3%/84.8%). For one VMAT arc without gating it was 99.6%.Conclusion: Gating is successfully applied during DTRT delivery on a TrueBeam system for the first time. Mechanical accuracy is similar for VMAT and DTRT deliveries with and without gating. Gating substantially improved dosimetric performance for DTRT and VMAT.
- 20 June 2023
- Published by Wiley in Medical Physics
- Vol. 50 (10) , 6535-6542
Open AccessTechnical note: Feasibility of gating for dynamic trajectory radiotherapy – Mechanical accuracy and dosimetric performance
Background: Dynamic trajectory radiotherapy (DTRT) extends state‐of‐the‐art volumetric modulated arc therapy (VMAT) by dynamic table and collimator rotations during beam‐on. The effects of intrafraction motion during DTRT delivery are unknown, especially regarding the possible interplay between patient and machine motion with additional dynamic axes.Purpose: To experimentally assess the technical feasibility and quantify the mechanical and dosimetric accuracy of respiratory gating during DTRT delivery.Methods: A DTRT and VMAT plan are created for a clinically motivated lung cancer case and delivered to a dosimetric motion phantom (MP) placed on the table of a TrueBeam system using Developer Mode. The MP reproduces four different 3D motion traces. Gating is triggered using an external marker block, placed on the MP. Mechanical accuracy and delivery time of the VMAT and DTRT deliveries with and without gating are extracted from the logfiles. Dosimetric performance is assessed by means of gamma evaluation (3% global/2 mm, 10% threshold).Results: The DTRT and VMAT plans are successfully delivered with and without gating for all motion traces. Mechanical accuracy is similar for all experiments with deviations <0.14° (gantry angle), <0.15° (table angle), <0.09° (collimator angle) and <0.08 mm (MLC leaf positions). For DTRT (VMAT), delivery times are 1.6–2.3 (1.6– 2.5) times longer with than without gating for all motion traces except one, where DTRT (VMAT) delivery is 5.0 (3.6) times longer due to a substantial uncorrected baseline drift affecting only DTRT delivery. Gamma passing rates with (without) gating for DTRT/VMAT were ≥96.7%/98.5% (≤88.3%/84.8%). For one VMAT arc without gating it was 99.6%.Conclusion: Gating is successfully applied during DTRT delivery on a TrueBeam system for the first time. Mechanical accuracy is similar for VMAT and DTRT deliveries with and without gating. Gating substantially improved dosimetric performance for DTRT and VMAT.
- Open Access
- 17 February 2023
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (4) , 044004
Auto-commissioning of a Monte Carlo electron beam model with application to photon MLC shaped electron fields
Objective. Presently electron beam treatments are delivered using dedicated applicators. An alternative is the usage of the already installed photon multileaf collimator (pMLC) enabling efficient electron treatments. Currently, the commissioning of beam models is a manual and time-consuming process. In this work an auto-commissioning procedure for the Monte Carlo (MC) beam model part representing the beam above the pMLC is developed for TrueBeam systems with electron energies from 6 to 22 MeV. Approach. The analytical part of the electron beam model includes a main source representing the primary beam and a jaw source representing the head scatter contribution each consisting of an electron and a photon component, while MC radiation transport is performed for the pMLC. The auto-commissioning of this analytical part relies on information pre-determined from MC simulations, in-air dose profiles and absolute dose measurements in water for different field sizes and source to surface distances (SSDs). For validation calculated and measured dose distributions in water were compared for different field sizes, SSDs and beam energies for eight TrueBeam systems. Furthermore, a sternum case in an anthropomorphic phantom was considered and calculated and measured dose distributions were compared at different SSDs. Main results. Instead of the manual commissioning taking up to several days of calculation time and several hours of user time, the auto-commissioning is carried out in a few minutes. Measured and calculated dose distributions agree generally within 3% of maximum dose or 2 mm. The gamma passing rates for the sternum case ranged from 96% to 99% (3% (global)/2 mm criteria, 10% threshold). Significance. The auto-commissioning procedure was successfully implemented and applied to eight TrueBeam systems. The newly developed user-friendly auto-commissioning procedure allows an efficient commissioning of an MC electron beam model and eases the usage of advanced electron radiotherapy utilizing the pMLC for beam shaping.
- 17 February 2023
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (4) , 044004
Open AccessAuto-commissioning of a Monte Carlo electron beam model with application to photon MLC shaped electron fields
Objective. Presently electron beam treatments are delivered using dedicated applicators. An alternative is the usage of the already installed photon multileaf collimator (pMLC) enabling efficient electron treatments. Currently, the commissioning of beam models is a manual and time-consuming process. In this work an auto-commissioning procedure for the Monte Carlo (MC) beam model part representing the beam above the pMLC is developed for TrueBeam systems with electron energies from 6 to 22 MeV. Approach. The analytical part of the electron beam model includes a main source representing the primary beam and a jaw source representing the head scatter contribution each consisting of an electron and a photon component, while MC radiation transport is performed for the pMLC. The auto-commissioning of this analytical part relies on information pre-determined from MC simulations, in-air dose profiles and absolute dose measurements in water for different field sizes and source to surface distances (SSDs). For validation calculated and measured dose distributions in water were compared for different field sizes, SSDs and beam energies for eight TrueBeam systems. Furthermore, a sternum case in an anthropomorphic phantom was considered and calculated and measured dose distributions were compared at different SSDs. Main results. Instead of the manual commissioning taking up to several days of calculation time and several hours of user time, the auto-commissioning is carried out in a few minutes. Measured and calculated dose distributions agree generally within 3% of maximum dose or 2 mm. The gamma passing rates for the sternum case ranged from 96% to 99% (3% (global)/2 mm criteria, 10% threshold). Significance. The auto-commissioning procedure was successfully implemented and applied to eight TrueBeam systems. The newly developed user-friendly auto-commissioning procedure allows an efficient commissioning of an MC electron beam model and eases the usage of advanced electron radiotherapy utilizing the pMLC for beam shaping.